CAS No.: | 2023788-19-2 |
---|---|
Classification: | Peptides |
Grade: | Research Peptide |
Specific Usage: | Weight Loss Peptides |
Content: | Standard |
Source: | Dry Powder |
Samples: |
---|
Customization: |
---|
Suppliers with verified business licenses
Products Name: Tirzepatide
CAS No.: 2023788-19-2
Purity: >99.0%
Appearance: White Lyophilized powder
Reconstitution: Required
Storage:After reconstitution store at 2°C - 8°C
Tirzepatide is a glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist, which is FDA-approved for treating type 2 diabetes mellitus. It is important to note that tirzepatide is not approved for treating type-1 diabetes mellitus and has not been studied in patients with pancreatitis. Tirzepatide is a GIP receptor and GLP-1 receptor agonist, leading to significantly improved glycemic control in type 2 diabetics and significant weight reduction.[1]
The FDA approved Tirzepatide in May 2022. Tirzepatide can also be used off-label for treating obesity. It is currently implemented as a second-line diabetes medication, similar to GLP-1 medications like semaglutide.[2] It is a once-a-week subcutaneous injectable medication with incremental dose increases.
Before ordering | Please send what items and what quantity you need |
Send quotation | We will send you a quotation in detail with total |
Payment ways chosen | Please choose one of the payment way you preferred. Our payment ways: Bank wire, Wise, Western Union, Crypto |
After payment | Please offer shipping address after payment for shipment. |
Tracking | We will provide the tracking after goods sent. |
Lead time | About 1-5 working days after payment |
Shipping time | About 8-15 days door to door |
After-sale service | Available always |
Suppliers with verified business licenses